![]() |
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
BRIEF-Enanta Pharmaceuticals an**unces AbbVie?s investigational HCV regimen receives U.S. FDA breakthrough therapy designation
* Enanta Pharmaceuticals an**unces AbbVie's investigationalHCV regimen receives U.S. FDA breakthrough therapy designation ??????? ??????: BRIEF-Enanta Pharmaceuticals an**unces AbbVie?s investigational HCV regimen receives || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|